Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates

SUMMARY: Persistence with osteoporosis therapy is critical for fracture risk reduction. This observational study evaluated medication-taking behaviour of women with postmenopausal osteoporosis receiving denosumab or oral ibandronate in real-world clinical practice in Bulgaria. Compared with ibandron...

Descripción completa

Detalles Bibliográficos
Autores principales: Petranova, T., Boyanov, M., Shinkov, A., Petkova, R., Intorcia, M., Psachoulia, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738460/
https://www.ncbi.nlm.nih.gov/pubmed/29264666
http://dx.doi.org/10.1007/s11657-017-0413-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738460/
https://www.ncbi.nlm.nih.gov/pubmed/29264666
http://dx.doi.org/10.1007/s11657-017-0413-5

Ejemplares similares